Kalaris Therapeutics, Inc. (NASDAQ:KLRS) IPO
IPO
Went public as Allovir, Inc. Priced at US$17.00 a share on Jul 29, 2020.
- Price
- US$17.00 a share
- Shares offered
- 16,250,000 shares of common stock
- Offering size
- US$276.3 million
- Underwriters' option
- Up to 2,437,500 more shares
- Underwriters
- MORGAN STANLEY, J.P. MORGAN, SVB LEERINK, PIPER SANDLER · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 3, 2020 |
| Filed publicly | Jul 6, 2020 |
| Amended once | Jul 23, 2020 |
| Shares registered with an exchange | Jul 27, 2020 |
| Declared effective by the SEC | Jul 29, 2020 |
| Final prospectus, with the price | Jul 30, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 30, 2020 |
| S-1MEF · Registration of more shares for the same offering | Jul 30, 2020 |
| EFFECT · Notice that a registration is effective | Jul 29, 2020 |
| CERT · Exchange's certificate of listing | Jul 29, 2020 |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Jul 29, 2020 |
| CORRESP · Letter to the SEC | Jul 28, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 27, 2020 |
| CORRESP · Letter to the SEC | Jul 27, 2020 |
| CORRESP · Letter to the SEC | Jul 27, 2020 |
| CORRESP · Letter to the SEC | Jul 27, 2020 |
| UPLOAD · Letter from the SEC | Jul 24, 2020 |
| CORRESP · Letter to the SEC | Jul 23, 2020 |
| S-1/A · Registration statement, amended | Jul 23, 2020 |
| CORRESP · Letter to the SEC | Jul 20, 2020 |
| CORRESP · Letter to the SEC | Jul 17, 2020 |
| UPLOAD · Letter from the SEC | Jul 14, 2020 |
| CORRESP · Letter to the SEC | Jul 6, 2020 |
| S-1 · Registration statement | Jul 6, 2020 |
| UPLOAD · Letter from the SEC | Jun 30, 2020 |
| DRS · Draft registration statement | Jun 3, 2020 |
From the cover of the final prospectus (424B4) filed Jul 30, 2020